What is Bangkok Genomics Innovation PCL Days Payable?
Bangkok Genomics Innovation PCLBKK:BKGI -0.93%45 Days Payable is 70.75 as of Dec. 2025, which is 97% above its 10-year median of 35.89. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 191 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks better than 51.83% on this metric.
The historical rank and industry rank for Bangkok Genomics Innovation PCL's Days Payable or its related term are showing as below:
BKK:BKGI'
s Days Payable Range Over the Past 10 Years
Min: 20.01 Med: 35.89 Max: 90.87
Current: 69.96
During the past 7 years, Bangkok Genomics Innovation PCL's highest Days Payable was 90.87. The lowest was 20.01. And the median was 35.89.
BKK:BKGI's Days Payable is ranked better than 51.83% of 191
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.09
vs BKK:BKGI: 69.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL Days Payable Chart
BKK:BKGI vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Genomics Innovation PCL Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Days Payable distribution charts can be found below:
* The bar in red indicates where Bangkok Genomics Innovation PCL's Days Payable falls into.
Bangkok Genomics Innovation PCL Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Days Payable of 70.75 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bangkok Genomics Innovation PCL and its competitors. This is 97% above median its historical median of 35.89. Over the past decade, Bangkok Genomics Innovation PCL's Days Payable has ranged from 20.01 to 90.87. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #92 out of 191 companies in the Medical Diagnostics & Research industry, placing it in the top 48.2%.
Is Bangkok Genomics Innovation PCL's Days Payable too high?
Bangkok Genomics Innovation PCL's current Days Payable of 70.75 is 97% above median its 10-year median of 35.89. Over the past 10 years, this metric has ranged from a low of 20.01 to a high of 90.87. The Medical Diagnostics & Research industry median Days Payable is 65.09. Bangkok Genomics Innovation PCL's value of 70.75 is 8.7% above this industry median. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #92 out of 191 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #92 out of 191 companies for Days Payable. This puts Bangkok Genomics Innovation PCL in the upper half of its industry. The industry median Days Payable is 65.09. Bangkok Genomics Innovation PCL's value of 70.75 is 8.7% above this benchmark. Historically, Bangkok Genomics Innovation PCL's own Days Payable has ranged from 20.01 to 90.87 over the past decade. While the company's 10-year median is 35.89 vs. the industry median of 65.09, Bangkok Genomics Innovation PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.09, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Genomics Innovation PCL's current Days Payable of 70.75 is 8.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current Days Payable is 70.75, which is 97% above median its own 10-year median of 35.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Days Payable of 70.75. The current Days Payable is 70.75, which is 97% above median its 10-year median of 35.89 and 8.7% above the Medical Diagnostics & Research industry median of 65.09. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Days Payable is 70.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bangkok Genomics Innovation PCL Business Description
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score
Get the complete analysis for BKK:BKGI
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BKGI has been successfully added to your 
